DexCom, Inc. (DXCM)

Price$64.62

Favorite Metrics

Price vs S&P 500 (26W)-7.78%

Price vs S&P 500 (4W)-10.14%

Market Capitalization$24.87B

P/E Ratio (Annual)29.74x

All Metrics

P/CF (Annual)17.26x

Book Value / Share (Quarterly)$7.14

P/TBV (Annual)9.68x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)17.01%

Cash Flow / Share (Quarterly)$2.80

Price vs S&P 500 (YTD)-6.57%

Gross Margin (TTM)62.09%

Net Profit Margin (TTM)17.94%

EPS (TTM)$2.07

10-Day Avg Trading Volume4.60M

EPS Excl Extra (TTM)$2.07

Revenue Growth (5Y)19.33%

EPS (Annual)$2.06

ROI (Annual)20.70%

Gross Margin (Annual)62.09%

Net Profit Margin (5Y Avg)13.55%

Cash / Share (Quarterly)$5.19

P/E Basic Excl Extra (TTM)29.74x

Revenue Growth QoQ (YoY)13.12%

EPS Growth (5Y)9.54%

P/E Normalized (Annual)29.74x

ROA (Last FY)13.19%

Revenue Growth TTM (YoY)15.60%

EBITD / Share (TTM)$2.87

ROE (5Y Avg)22.13%

Operating Margin (TTM)19.56%

Cash Flow / Share (Annual)$2.80

P/B Ratio9.06x

P/B Ratio (Quarterly)9.43x

Net Income / Employee (Annual)$0

EV / Revenue (TTM)5.42x

Net Interest Coverage (TTM)978.00x

ROA (TTM)11.98%

EPS Growth QoQ (YoY)79.65%

EV / EBITDA (TTM)21.71x

EPS Incl Extra (Annual)$2.06

Current Ratio (Annual)1.88x

Quick Ratio (Quarterly)1.56x

3-Month Avg Trading Volume4.89M

52-Week Price Return-5.76%

EV / Free Cash Flow (Annual)23.44x

P/E Incl Extra (TTM)29.74x

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$6.95

P/S Ratio (Annual)5.33x

Asset Turnover (Annual)0.74x

52-Week High$89.98

Operating Margin (5Y Avg)15.05%

EPS Excl Extra (Annual)$2.06

CapEx CAGR (5Y)12.81%

Tangible BV CAGR (5Y)56.65%

26-Week Price Return-0.89%

Quick Ratio (Annual)1.56x

13-Week Price Return-6.67%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)1.88x

Enterprise Value$25,246.965

Revenue / Share Growth (5Y)20.19%

Asset Turnover (TTM)0.67x

Book Value / Share Growth (5Y)8.47%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)3.02x

Pretax Margin (Annual)23.35%

Cash / Share (Annual)$5.19

3-Month Return Std Dev32.88%

Gross Margin (5Y Avg)64.50%

Net Income / Employee (TTM)$0

EBITDA CAGR (5Y)31.06%

EBITDA Interim CAGR (5Y)24.30%

ROE (Last FY)30.46%

Net Interest Coverage (Annual)32.41x

EPS Basic Excl Extra (Annual)$2.06

P/FCF (TTM)23.09x

Receivables Turnover (TTM)4.20x

EV / Free Cash Flow (TTM)23.44x

Total Debt / Equity (Quarterly)0.47x

EPS Incl Extra (TTM)$2.07

Receivables Turnover (Annual)4.20x

ROI (TTM)17.50%

P/S Ratio (TTM)5.33x

Pretax Margin (5Y Avg)16.89%

Revenue / Share (Annual)$11.50

Tangible BV / Share (Annual)$6.95

Forward P/E25.99x

Free OCF CAGR (5Y)31.25%

Price vs S&P 500 (52W)-40.39%

P/E Ratio (TTM)29.74x

EPS Growth TTM (YoY)47.91%

Year-to-Date Return-2.64%

5-Day Price Return2.65%

EPS Normalized (Annual)$2.06

ROA (5Y Avg)8.29%

Net Profit Margin (Annual)17.94%

Month-to-Date Return2.90%

Cash Flow / Share (TTM)$1.28

EBITD / Share (Annual)$2.88

EPS Growth (3Y)37.23%

Operating Margin (Annual)19.56%

LT Debt / Equity (Annual)0.45x

P/CF (TTM)17.26x

ROI (5Y Avg)11.71%

P/E Excl Extra (TTM)29.74x

LT Debt / Equity (Quarterly)0.45x

EPS Basic Excl Extra (TTM)$2.07

P/TBV (Quarterly)9.68x

P/B Ratio (Annual)9.43x

Inventory Turnover (TTM)3.02x

Pretax Margin (TTM)23.35%

Book Value / Share (Annual)$7.14

Price vs S&P 500 (13W)-9.05%

Net Margin Growth (5Y)-8.86%

Beta1.48x

P/FCF (Annual)23.09x

Revenue / Share (TTM)$11.69

ROE (TTM)32.44%

52-Week Low$54.11

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.30

4.22

4.24

Industry Peers — Surgical & Medical Instruments(108)

Symbol	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
DXCMDexCom, Inc.	5.33x	19.33%	62.09%	19.56%	$64.62
SYKStryker Corporation	5.17x	11.84%	64.57%	19.43%	$338.34
BSXBoston Scientific Corp.	4.58x	15.16%	69.01%	18.00%	$60.99
MMM3M Company	3.21x	-4.97%	39.92%	18.55%	$151.40
MDLNMedline Inc. Class A common stock	2.20x	—	26.44%	7.78%	$48.26
BDXBecton, Dickinson and Co.	2.06x	6.32%	46.42%	12.15%	$158.64
RMDResMed Inc.	6.07x	11.72%	60.85%	33.70%	$226.14
WSTWest Pharmaceutical Services, Inc.	6.29x	7.44%	35.91%	19.03%	$278.00
PODDInsulet Corporation	5.19x	24.53%	71.63%	12.92%	$200.87
PENPenumbra, Inc.	9.24x	20.16%	67.14%	13.48%	$329.71
GMEDGLOBUS MEDICAL INC	4.37x	30.08%	67.41%	20.33%	$96.82

About

DexCom manufactures continuous glucose monitoring systems that provide an alternative to traditional blood glucose testing for diabetes management. The company's CGM technology integrates with insulin pumps from Insulet and Tandem to enable automated insulin delivery. Products are distributed through medical equipment distributors and retail pharmacies.